1

Medulloblastoma Drug Market is driven by rising prevalence of pediatric brain tumors

 News Discuss 
The Global Medulloblastoma Drug Market is estimated to be valued at USD 4.36 Bn in 2025 and is expected to reach USD 6.69 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032. https://justpaste.me/OxDF3

Comments

    No HTML

    HTML is disabled


    Report Page

Who Upvoted this Story

Search

Published News